ZCMD ZCMD
Company Profile ↓Company Overview
ZCMD (ZCMD) is a publicly traded company listed on with a market capitalization of $30.59K. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Carries low leverage with a debt-to-equity ratio of 0.14.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $11.37M (-28.3% YoY); net profit $-6.31M.
- Trailing 12 Months Year-on-year growth — revenue -28.3%.
- 5-Year Trend Long-term compounding — revenue CAGR -7.0%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -7.02% |
| 1 Year: | -28.30% |
Stock Price Performance
| 1 Year: | -99.91% |
| 6 Months: | -99.56% |
| 3 Months: | -64.40% |
| 1 Month: | -26.30% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)28.30 · Oversold
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Generates positive free cash flow.
CONS
- Revenue declined at -7.0% CAGR over 5 years.
- Trading 99.9% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 14.15M | 19.43M | 15.86M | 11.37M |
| Cost of Revenue | - | 7.79M | 10.92M | 6.95M | 6.25M |
| Gross Profit | - | 6.36M | 8.51M | 8.91M | 5.12M |
| Operating Expenses | - | 9.31M | 13.92M | 9.25M | 11.31M |
| Operating Income | - | -2.95M | -5.41M | -341.27K | -6.19M |
| EBITDA | - | -2.22M | -4.49M | 87.09K | -5.87M |
| Interest Expense | - | - | - | - | - |
| Pretax Income | - | -2.55M | -11.98M | 61.76K | -5.77M |
| Tax Provision | - | 272.31K | -669.76K | 335.17K | 46.18K |
| Net Income | - | -2.94M | -11.34M | -643.23K | -6.31M |
| Diluted EPS | 71.42 | -841.46 | -3,239.19 | -92.07 | - |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 38.61M | 24.42M | 25.88M | 24.15M |
| Current Assets | - | 22.70M | 18.71M | 18.71M | 16.96M |
| Cash & Equivalents | - | 11.52M | 7.55M | 7.84M | 8.10M |
| Inventory | - | 189.11K | 592.38K | 586.22K | 0 |
| Receivables | - | 6.77M | 2.55M | 4.68M | 2.78M |
| Total Liabilities | - | 5.60M | 3.38M | 1.73M | 1.55M |
| Current Liabilities | - | 4.17M | 2.68M | 1.53M | 1.53M |
| Long Term Debt | - | - | - | - | - |
| Total Debt | - | 1.70M | 808.16K | 57.52K | 26.08K |
| Total Equity | - | 29.93M | 18.01M | 20.84M | 18.63M |
| Shares Outstanding | - | 3.32K | 3.32K | 33.94K | 41.34K |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | -661.74K | 54.23K | -1.47M | 845.39K |
| Investing Cash Flow | - | -3.35M | -3.75M | -1.81M | -826.60K |
| Financing Cash Flow | - | 1.85M | 0 | 3.84M | 0 |
| Capital Expenditure | - | -1.86M | -839.74K | -3.05M | -152.56K |
| Free Cash Flow | - | -2.52M | -785.51K | -4.52M | 692.83K |
| Net Change in Cash | - | -2.16M | -3.70M | 557.20K | 18.79K |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 44.9% | 43.8% | 56.2% | 45.0% |
| Operating Margin % | - | -20.9% | -27.8% | -2.2% | -54.4% |
| Net Margin % | - | -20.8% | -58.3% | -4.1% | -55.5% |
| ROE % | - | -9.8% | -63.0% | -3.1% | -33.9% |
| ROCE % | - | -8.6% | -24.9% | -1.4% | -27.4% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for ZCMD
Zhongchao Inc. Announces $5.0 Million Registered Direct Offering
Zhongchao Inc ("Zhongchao" or the "Company") (NASDAQ: ZCMD), today announced that it has entered into a definitive agreement with certain investors for the purchase and sale of an aggregate of 4,545,455 of the Company's Class A Ordinary Sha…
Zhongchao Inc. Announces 1-for-3 Share Consolidation
Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced that the Company will effectuate a 1-for-3 share…
Zhongchao Inc. Announces 1-for-31 Share Consolidation
Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced that the Company will effectuate a 1-for-31 shar…
Zhongchao Inc. Announces Pricing of $5 Million Best Efforts Public Offering
Zhongchao Inc. ("Zhongchao" or the "Company") (NASDAQ: ZCMD), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced the pricing of a best efforts public offering wi…
Zhongchao Inc. Announces 1-for-8 Share Consolidation
Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced that the Company will effectuate a 1-for-8 share…
Companies Like Zhongchao (NASDAQ:ZCMD) Are In A Position To Invest In Growth
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
ZCMD — Frequently Asked Questions
What is the current share price of ZCMD?
As of 2026-09-16 18:39 PDT, ZCMD trades at $0.74 on NASDAQ/NYSE. Its 52-week range is $0.73 to $930.00.
What is the market capitalisation of ZCMD?
ZCMD has a market capitalisation of $30.59K on NASDAQ/NYSE.
What is the P/E ratio of ZCMD?
ZCMD trades at a trailing price-to-earnings (P/E) ratio of -0.01.
What is the return on equity (ROE) of ZCMD?
ZCMD has a return on equity (ROE) of -33.87%. Its return on capital employed (ROCE) is -27.37%.
Is ZCMD a good stock to buy?
This page provides a data-driven analysis of ZCMD, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.